Why ZenoWELL taVNS Stimulates Concha Cavum and Concha Cymba areas?

Transcutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive neuromodulation technology. By electrically stimulating the auricular branch of the vagus nerve (ABVN) on the ear's surface, taVNS can regulate both the autonomic and central nervous systems. The ZenoWELL taVNS device targets the concha cavum and concha cymba areas primarily for two reasons, as supported by anatomical and neuroimaging findings.

First, the design of the ZenoWELL taVNS earpiece is based on the anatomical distribution of the ABVN. The concha cymba is exclusively innervated by the ABVN (100% dominance), while other auricular regions show varying degrees of ABVN innervation: the antihelix (73%), concha cavum (45%), tragus (45%), crus of helix (20%), and crura of anthelix (9%) [1,2]. This anatomical evidence establishes the concha cymba as our primary target area. ZenoWELL engineers subsequently designed the earpiece geometry to conform to the concha cymba's topography. To optimize user comfort, convenience, and stability while maintaining ergonomic principles, we expanded the stimulation area to include the concha cavum, thereby completing the electrical circuit required for effective stimulation.

Second, our design was empirically validated by neuroimaging data from previous studies. Neuroimaging studies using fMRI and EEG have demonstrated that stimulation of the concha cavum modulates activity in the brainstem's vagal afferent nuclei[3]. Furthermore, simultaneous stimulation of both concha cavum and concha cymba elicited significantly stronger vagus somatosensory evoked potential (VSEP) signals compared to stimulating either area alone[4].

Based on these considerations, we engineered the earpiece with dual stimulation points targeting the concha cavum and concha cymba. Given the substantial anatomical variability in ear morphology across populations, a universal design proves inadequate. To address this, we developed an adaptive silicone sleeve capable of accommodating diverse ear dimensions. The material's softness and conductivity were precisely calibrated to conform to auricular topography while maintaining optimal surface contact, thereby ensuring consistent stimulation efficacy.

Reference

  1. Peuker E T, Filler T J. The nerve supply of the human auricle[J]. Clinical Anatomy, 2002, 15(1): 35-37.
  2. Wang Y, Li S Y, Wang D, et al. Transcutaneous auricular vagus nerve stimulation: from concept to application[J]. Neuroscience Bulletin, 2021, 37: 853-862.
  3. Borgmann D, Rigoux L, Kuzmanovic B, et al. Modulation of fMRI brainstem responses by transcutaneous vagus nerve stimulation[J]. Neuroimage, 2021, 244: 118566.
  4. Butt M F, Albusoda A, Farmer A D, et al. The anatomical basis for transcutaneous auricular vagus nerve stimulation[J]. Journal of anatomy, 2020, 236(4): 588-611.

Verwandte Beiträge

Science Update: taVNS Matches Antidepressants in Treating Depression—With Fewer Side Effects

Introduction Two newly published scientific reviews provide compelling evidence for the use of transcutaneous auricular vagus nerve stimulation (taVNS) as a safe, effective intervention...
Beitrag von Dr. ShawJane
Jun 13 2025

Transcutaneous Auricular Vagus Nerve Stimulation: A Promising Tool for Long COVID Recovery

Introduction As research into post-COVID conditions grows, more studies point to taVNS (transcutaneous auricular vagus nerve stimulation) as a safe, non-invasive way to ease...
Beitrag von Dr. ShawJane
Jun 10 2025

Lastest Meta Analysis of TaVNS in Insomnia

Struggling with Sleepless Nights? taVNS Might Be the Non-Invasive Solution You've Been Waiting For. Insomnia affects roughly one-third of adults worldwide, impacting mood, energy,...
Beitrag von Dr. ShawJane
Jun 04 2025

TaVNS Safety Breakthrough: New Meta-Analysis Reveals 94% No Long-term Side Effects

Introduction In recent years, transcutaneous auricular vagus nerve stimulation (taVNS)—a non-invasive neuromodulation technique—has garnered significant attention in neuroscience and clinical practice. Widely used to treat...
Beitrag von Dr. ShawJane
May 23 2025

Clinical exploration of taVNS in the treatment of HIV/AIDS patients' depression

Depressive symptoms are not uncommon among HIV/AIDS patients, but have been neglected for a long time. Studies show that about 20% -30% of HIV-infected...
Beitrag von Dr. ShawJane
May 22 2025

TaVNS optimiert die Entscheidungsgenauigkeit – Erkenntnisse aus einer aktuellen Studie zur Hirnstimulation

Einführung Haben Sie beim Treffen einer Entscheidung schon einmal Folgendes erlebt: Nach einem Fehler fällt es Ihnen immer schwer, sich zu konzentrieren, und die...
Beitrag von Dr. ShawJane
May 13 2025

Vom Körper zur Resilienz: Die Rolle des Vagusnervs für das emotionale Wohlbefinden – Erkenntnisse aus einer bahnbrechenden Studie in der biologischen Psychiatrie

Der Vagusnerv: Brücke zwischen Körper und Geist Interozeption – die Fähigkeit, innere Körpersignale wie Herzschlag, Atmung und Darmaktivität wahrzunehmen – ist grundlegend für emotionale...
Beitrag von Dr. ShawJane
May 08 2025